Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alla Skapenko

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Blood|March 27, 2012
Maturation-related histone modifications in the PU.1 promoter regulate Th9-cell developmentAndreas Ramming, David Druzd, Jan Leipe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursorsAlla Skapenko, Joachim R Kalden, Peter E Lipsky, et al.
Annals of the Rheumatic Diseases|June 28, 2020
Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximabHendrik Schulze-Koops, Klaus Krueger, Inka Vallbracht, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 1, 2014
Increased Th17 cell frequency and poor clinical outcome in rheumatoid arthritis are associated with a genetic variant in the IL4R gene, rs1805010Jan Leipe, Markus A Schramm, Iryna Prots, et al.
Annals of the Rheumatic Diseases|August 6, 2020
Treatment of patients with inflammatory rheumatic diseases with rituximab should be carefully considered during the SARS-CoV-2/COVID-19 pandemic. Response to: 'Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothesis of Schulze-Koops et al' by Benucci <i>et al</i>Hendrik Schulze-Koops, Klaus Krueger, Inka Vallbracht Vallbracht, et al.
Biochimica Et Biophysica Acta|November 21, 2015
Methylation of an intragenic alternative promoter regulates transcription of GARPSonja Haupt, Viktoria Sophie Apollonia Söntgerath, Jan Leipe, et al.
European Journal of Immunology|November 1, 2005
The p38 mitogen-activated protein kinase regulates effector functions of primary human CD4 T cellsFrancis Dodeller, Alla Skapenko, Joachim R Kalden, et al.
Arthritis Research & Therapy|March 28, 2006
IFNGR1 single nucleotide polymorphisms in rheumatoid arthritisStefan Mattyasovszky, Alla Skapenko, Joachim R Kalden, et al.
Cureus|July 4, 2024
Inflammatory Back Pain and Psoriasis: Expecting Spondyloarthritis, Discovering LymphomaFabian T H Ullrich, Nina Hesse, Denis Poddubnyy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Generation and regulation of human Th1-biased immune responses in vivo: a critical role for IL-4 and IL-10Alla Skapenko, Gerald U Niedobitek, Joachim R Kalden, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Blood|March 27, 2012
Maturation-related histone modifications in the PU.1 promoter regulate Th9-cell developmentAndreas Ramming, David Druzd, Jan Leipe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursorsAlla Skapenko, Joachim R Kalden, Peter E Lipsky, et al.
Annals of the Rheumatic Diseases|June 28, 2020
Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximabHendrik Schulze-Koops, Klaus Krueger, Inka Vallbracht, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 1, 2014
Increased Th17 cell frequency and poor clinical outcome in rheumatoid arthritis are associated with a genetic variant in the IL4R gene, rs1805010Jan Leipe, Markus A Schramm, Iryna Prots, et al.
Annals of the Rheumatic Diseases|August 6, 2020
Treatment of patients with inflammatory rheumatic diseases with rituximab should be carefully considered during the SARS-CoV-2/COVID-19 pandemic. Response to: 'Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothesis of Schulze-Koops et al' by Benucci <i>et al</i>Hendrik Schulze-Koops, Klaus Krueger, Inka Vallbracht Vallbracht, et al.
Biochimica Et Biophysica Acta|November 21, 2015
Methylation of an intragenic alternative promoter regulates transcription of GARPSonja Haupt, Viktoria Sophie Apollonia Söntgerath, Jan Leipe, et al.
European Journal of Immunology|November 1, 2005
The p38 mitogen-activated protein kinase regulates effector functions of primary human CD4 T cellsFrancis Dodeller, Alla Skapenko, Joachim R Kalden, et al.
Arthritis Research & Therapy|March 28, 2006
IFNGR1 single nucleotide polymorphisms in rheumatoid arthritisStefan Mattyasovszky, Alla Skapenko, Joachim R Kalden, et al.
Cureus|July 4, 2024
Inflammatory Back Pain and Psoriasis: Expecting Spondyloarthritis, Discovering LymphomaFabian T H Ullrich, Nina Hesse, Denis Poddubnyy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Generation and regulation of human Th1-biased immune responses in vivo: a critical role for IL-4 and IL-10Alla Skapenko, Gerald U Niedobitek, Joachim R Kalden, et al.
Pageof 6